COaching Lifestyle Intervention for FErtility (COLIFE)

August 6, 2021 updated by: Maritta Poyhonen-Alho, Helsinki University Central Hospital
In Finland, every third woman is overweight (BMI>25) and 11,5% obese (BMI>30). Cohort and national studies reveal that 46% of fertile-aged men have BMI≥25 and 20% BMI≥30. Overweight has negative impact on both female and male fertility and weakens markedly the results of infertility treatments. In this study, 780 infertile couples will be randomized to control group (conventional infertility treatment) and lifestyle intervention arm undergoing 4 sessions of video-mediated motivational interview, anthropometric measurements, laboratory tests and epigenetic samples. Economic evaluation of the intervention will also be performed.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

1560

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • infertility
  • BMI 27-34.9 kg/m2

Exclusion Criteria:

  • no mobile device available
  • evident sperm defect or ovarian tube block
  • hinder for fluent treatment schedule due to the subjec´s obstacle (inadequate language skills, major time table problems)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Conventional treatment
Active Comparator: Intervention
Motivational interview
Life Style intervention including physical activity, diet, sleep and stress

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Behavior change
Time Frame: 6 months
score from 1 to 4: (smoking + daily vegetable, fruit and berry use >500g + BMI 19-27 + 150 min of moderate exercise/week) No=0, Yes=1 measured at the beginning, at 3 and 6 months
6 months
Live birth rate
Time Frame: 3 years
Number of live children born
3 years
Weight change
Time Frame: 6 months
weight in kg measured without shoes and with light clothing at the beginning, at 3 and 6 months
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Infertility treatments, number
Time Frame: 3 years
Number of infertility treatments needed for a live birth
3 years
Infertility treatments, mode
Time Frame: 3 years
Mode of infertility treatments needed for a live birth (including ovulation induction, insemination, IVF, ICSI)
3 years
Miscarriage rate
Time Frame: 3 years
Number of miscarriages
3 years
Height
Time Frame: 0 months
Measured without shoes (cm)
0 months
Weight
Time Frame: 0 months
Measured without shoes and with light clothing (kg)
0 months
Weight
Time Frame: 3 months
Measured without shoes and with light clothing (kg)
3 months
Weight
Time Frame: 6 months
Measured without shoes and with light clothing (kg)
6 months
Body mass index
Time Frame: 0 months
Weight in kilograms divided by the square of height in meters
0 months
Body mass index
Time Frame: 3 months
Weight in kilograms divided by the square of height in meters
3 months
Body mass index
Time Frame: 6 months
Weight in kilograms divided by the square of height in meters
6 months
Body composition
Time Frame: 0 months
Bioimpedance method
0 months
Body composition
Time Frame: 3 months
Bioimpedance method
3 months
Body composition
Time Frame: 6 months
Bioimpedance method
6 months
Waist circumference
Time Frame: 0 months
measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm)
0 months
Waist circumference
Time Frame: 3 months
measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm)
3 months
Waist circumference
Time Frame: 6 months
measured at midpoint between the lower margin of the last palpable rib and the top of the iliac crest (cm)
6 months
Self-reported physical activity
Time Frame: 0 months
Minutes per week, International Physical Activity Questionnaire - Short Form
0 months
Self-reported physical activity
Time Frame: 6 months
Minutes per week, International Physical Activity Questionnaire - Short Form
6 months
Physical activity
Time Frame: 0 months
Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer
0 months
Physical activity
Time Frame: 3 months
Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer
3 months
Physical activity
Time Frame: 6 months
Amount of weekly physical activity, data from Oura ring 3-dimensional accelerometer
6 months
Maximal oxygen uptake
Time Frame: 0 months
Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990
0 months
Maximal oxygen uptake
Time Frame: 3 months
Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990
3 months
Maximal oxygen uptake
Time Frame: 6 months
Functional aerobic capacity prediction model (N-Ex BMI) by Johnson et al 1990
6 months
Dietary content
Time Frame: 0 months
FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)
0 months
Dietary content
Time Frame: 6 months
FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)
6 months
Dietary patterns
Time Frame: 0 months
FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)
0 months
Dietary patterns
Time Frame: 6 months
FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a)
6 months
Folate
Time Frame: 0 months
Plasma folate concentration
0 months
Folate
Time Frame: 6 months
Plasma folate concentration
6 months
Vitamin-D
Time Frame: 0 months
Plasma vitamin-D concentration
0 months
Vitamin-D
Time Frame: 6 months
Plasma vitamin-D concentration
6 months
Zinc
Time Frame: 0 months
Plasma zinc concentration
0 months
Zinc
Time Frame: 6 months
Plasma zinc concentration
6 months
Carbohydrates
Time Frame: 0 months
Amount of daily carbohydrates in diet , FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
Carbohydrates
Time Frame: 6 months
Amount of daily carbohydrates in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
Protein
Time Frame: 0 months
Amount of daily proteins in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
Protein
Time Frame: 6 months
Amount of daily proteins in diet, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
Alcohol
Time Frame: 0 months
Alcohol consumption per week, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
Alcohol
Time Frame: 6 months
Alcohol consumption per week, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
n-3 fatty acids
Time Frame: 0 months
Amount of daily n-3 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
n-3 fatty acids
Time Frame: 6 months
Amount of daily n-3 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
n-6 fatty acids
Time Frame: 0 months
Amount of daily n-6 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
n-6 fatty acids
Time Frame: 6 months
Amount of daily n-6 fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
Saturated fatty acids
Time Frame: 0 months
Amount of daily saturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
Saturated fatty acids
Time Frame: 6 months
Amount of daily saturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
Monounsaturated fatty acids
Time Frame: 0 months
Amount of daily monounsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
Monounsaturated fatty acids
Time Frame: 6 months
Amount of daily monounsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
Polyunsaturated fatty acids
Time Frame: 0 months
Amount of daily polyunsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
0 months
Polyunsaturated fatty acids
Time Frame: 6 months
Amount of daily polyunsaturated fatty acids, FinTerveys dietary questionnaire (https://thl.fi/documents/189940/4779595/FT17_FFQ_ENG_paino.pdf/4a2ef46b-272e-4bb4-827c-e1cb1314f09a
6 months
Sleep
Time Frame: 0 months
Quality of sleep, Basic Nordic Sleep Questionnaire (BNSQ)
0 months
Sleep
Time Frame: 6 months
Quality of sleep, Basic Nordic Sleep Questionnaire (BNSQ)
6 months
Sleep, measured
Time Frame: 0 months
Quality, sleep disruptions, total sleep duration registered by Oura ring application
0 months
Sleep, measured
Time Frame: 3 months
Quality, sleep disruptions, total sleep duration registered by Oura ring application
3 months
Sleep, measured
Time Frame: 6 months
Quality, sleep disruptions, total sleep duration registered by Oura ring application
6 months
Stress recovery
Time Frame: 0 months
Night-time heart rate variability regisered by Oura ring application
0 months
Stress recovery
Time Frame: 3 months
Night-time heart rate variability registered by Oura ring application
3 months
Stress recovery
Time Frame: 6 months
Night-time heart rate variability registered by Oura ring application
6 months
Anxiety and depression
Time Frame: 0 months
Hospital Anxiety and Depression Scale (HADS)
0 months
Anxiety and depression
Time Frame: 3 months
Hospital Anxiety and Depression Scale (HADS)
3 months
Anxiety and depression
Time Frame: 6 months
Hospital Anxiety and Depression Scale (HADS)
6 months
Fertility quality of life
Time Frame: 0 months
FertiQoL International Questionnaire
0 months
Fertility quality of life
Time Frame: 6 months
FertiQoL International Questionnaire
6 months
Depression
Time Frame: 0 months
Edinburgh Postnatal Depression Scale (EPDS) Questionnaire
0 months
Depression
Time Frame: 6 months
Edinburgh Postnatal Depression Scale (EPDS) Questionnaire
6 months
Self-determined motivation for physical activity
Time Frame: 0 months
Behavioral Regulations for Exercise Questionnaire (BREQ-3, Markland, D. & Tobin, 2004). Includes the subscales: Amotivation, External regulation, Introjected regulation, Identified regulation, Integrated regulation, Intrinsic regulation.
0 months
Self-determined motivation for physical activity
Time Frame: 6 months
Behavioral Regulations for Exercise Questionnaire (BREQ-3, Markland, D. & Tobin, 2004). Includes the subscales: Amotivation, External regulation, Introjected regulation, Identified regulation, Integrated regulation, Intrinsic regulation
6 months
Intention and action planning for physical activity; Intention to increase physical activity
Time Frame: 0 months
Three (adapted) items from the Health Action Process Approach Questionnaire, (Schwarzer R. Modeling health behaviour change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol, 2008; 57:1-29)
0 months
Intention and action planning for physical activity; Intention to increase physical activity
Time Frame: 6 months
Three (adapted) items from the Health Action Process Approach Questionnaire (Schwarzer R. Modeling health behaviour change: how to predict and modify the adoption and maintenance of health behaviors. Appl Psychol, 2008; 57:1-29)
6 months
Self-efficacy for physical activity
Time Frame: 0 months
18-item scale developed by Albert Bandura (Bandura A. 2006). Guide for constructing self-efficacy scales. In: Pajares F, Urdan T (eds)Self-efficacy beliefs of adolescents. Information Age, Charlotte, pp 307-337)
0 months
Self-efficacy for physical activity
Time Frame: 6 months
18-item scale developed by Albert Bandura (Bandura A. 2006). Guide for constructing self-efficacy scales. In: Pajares F, Urdan T (eds)Self-efficacy beliefs of adolescents. Information Age, Charlotte, pp 307-337)
6 months
Pregnancy complications
Time Frame: 3 years
Number of pregnancy complications (gestational diabetes, pre-eclampsia, hypertension, fetal growth disorders, preterm birth)
3 years
Delivery complications
Time Frame: 3 years
Number of delivery complications (cesarean section, assisted vaginal delivery, hemorrhage)
3 years
Neonatal outcome
Time Frame: 3 years
Birth weight, cord pH, Apgar score
3 years
Body composition of the newborn
Time Frame: At birth
Bioimpedance method
At birth
Growth of the child
Time Frame: Up to 16 years of age
From the records of the national child care centers and schools
Up to 16 years of age
Sperm epigenetic profile
Time Frame: 0 months
Determination of heritable phenotype
0 months
Sperm epigenetic profile
Time Frame: 6 months
Determination of heritable phenotype
6 months
Transcriptome
Time Frame: 0 months
RNA-sequencing
0 months
Transcriptome
Time Frame: 6 months
RNA-sequencing
6 months
Sperm oxidative stress
Time Frame: 0 months
the Male infertility Oxidative System test (MiOXSYS)
0 months
Sperm oxidative stress
Time Frame: 6 months
the Male infertility Oxidative System test (MiOXSYS)
6 months
A cost-utility of the intervention
Time Frame: 3 years
analysis based on WHOQOL-BREF Questionnaire and FertiQoL, relating the quality-adjusted life years (QALYS) to the costs of the intervention
3 years
QALY baseline
Time Frame: 0 months
WHOQOL-BREF Questionnaire and FertiQoL International Questionnaire
0 months
QALY end point
Time Frame: 6 months
WHOQOL-BREF Questionnaire and FertiQoL International Questionnaire
6 months
Cost-effectiveness
Time Frame: 3 years
ICER
3 years
Static postural balance
Time Frame: 0 months
Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)
0 months
Static postural balance
Time Frame: 1st trimester of pregnancy
Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)
1st trimester of pregnancy
Static postural balance
Time Frame: 2nd trimester of pregnancy
Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)
2nd trimester of pregnancy
Static postural balance
Time Frame: 3rd trimester of pregnancy
Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)
3rd trimester of pregnancy
Static postural balance
Time Frame: 3 months postpartum
Absolute reach distance measured on balance board, cm (FTC Functional training Company GmbH, AM Haag 10 D-82166 Gräfelfing Germany)
3 months postpartum
Perception of stress
Time Frame: 0 months
Perceived Stress Scale by Sheldon Cohen
0 months
Perception of stress
Time Frame: 3 months
Perceived Stress Scale by Sheldon Cohen
3 months
Perception of stress
Time Frame: 6 months
Perceived Stress Scale by Sheldon Cohen
6 months
Personality dimensions
Time Frame: 0 months
The Big Five Personality Test
0 months
Personality dimensions
Time Frame: 6 months
The Big Five Personality Test
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Juha Tapanainen, professor, Helsinki University Central Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2021

Primary Completion (Anticipated)

September 1, 2024

Study Completion (Anticipated)

September 1, 2025

Study Registration Dates

First Submitted

October 9, 2020

First Submitted That Met QC Criteria

October 9, 2020

First Posted (Actual)

October 19, 2020

Study Record Updates

Last Update Posted (Actual)

August 12, 2021

Last Update Submitted That Met QC Criteria

August 6, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

According to request and after consideration of the study group

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fertility Disorders

Clinical Trials on Life Style

Subscribe